Lauded public health researcher also worked for industry, revealing entanglements of science

By David Heath

A late UC Berkeley dean pushed public health reforms — while also working for industry, revealing the deep reach of corporate science.

High bladder cancer rate shrouds New York plant, exposing chemical hazards in the workplace

By Jim Morris

A decades-long spate of bladder cancer at a Goodyear plant in Niagara Falls, N.Y. spotlights limits of regulation over dangerous chemicals.

Facing lawsuits over deadly asbestos, paper giant launched secretive research program

By Jim Morris

Facing 60,000 asbestos claims over a product it once sold, Georgia-Pacific responded with a legal pushback — and secretive science.

In new battleground over toxic reform, American Chemistry Council targets the states

By Ronnie Greene

The fight between industry and activists over regulation of toxic chemicals has shifted from Washington, D.C., to state venues.

Read 'Toxic Clout' via e-book

Read the 'Toxic Clout' series on your mobile device.

Berkeley training helps researchers 'work around' potential conflicts

By David Heath

New NIH conflict rules don't do enough, senator says, to weed out conflicts between researchers and industry: A UC Berkeley case study.

California bypasses feds, presses ahead on regulation of toxic chemicals

By Ronnie Greene

The state formally adopts new rules that go well beyond the flimsy federal protection net weakened by decades of D.C. delay.

Best of friends: Baltimore mayor, chemical lobbyist

By Ronnie Greene

As she lobbies City Hall, the ACC's Lisa Harris Jones remains exceedingly close to Mayor Stephanie Rawlings-Blake.

Session for state officials "intended to educate," not influence, corporate sponsor says

By Ronnie Greene

A forum for state officials at Procter & Gamble headquarters raises questions about industry's role in shaping environmental health policy.

Industry muscle targets federal 'Report on Carcinogens'

By Jim Morris and Chris Hamby

Chemical industry groups are pursuing hearings and legal fights challenging a government cancer report — part of a growing rift with HHS.

Lautenberg chemical bill drawing skepticism

By Sam Pearson

A much-heralded bill to reform chemical safety is stirring concern among some state officials and environmental groups.

Cancer-cluster study seeking to debunk 'Erin Brockovich' has glaring weaknesses

By David Heath

An often-cited study finds no cancer cluster in Hinkley, Calif. But it fails to focus on people who drank poisoned water.

'Chemicals of Concern' list still wrapped in OMB red tape

By Jim Morris

The EPA wants to release a list of 'chemicals of concern' for public comment, but the list remains locked up with the White House OMB.

EPA adds safeguards to spotlight conflicts on scientific panels

By David Heath and Ronnie Greene

The Environmental Protection Agency announced new steps Friday to help reveal potential conflicts of interest in scientific review panels.

How industry scientists stalled action on carcinogen

By David Heath

Tens of millions of Americans drink tap water tainted with chromium. But industry pushback has made it hard for the EPA to regulate.

EPA unaware of industry ties on cancer review panel

By David Heath and Ronnie Greene

An EPA panel appointed to study hexavalent chromium included scientists who had consulted for industry in lawsuits.

Ouster of scientist from EPA panel shows industry clout

By Ronnie Greene and David Heath

The removal of a respected Maine toxicologist from a panel six years ago reveals industry influence on EPA's IRIS program